ASSOCIATION OF HISTOLOGIC MEASUREMENT WITH ENDOSCOPIC OUTCOMES WITH MIRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

被引：0
|
作者：
Magro, Fernando [2 ]
De Hertogh, Gert [3 ]
Protic, Marijana [1 ]
Chan, Lai Shan [1 ]
Pollack, Paul [1 ]
Feagan, Brian [4 ]
Harpaz, Noam [5 ]
Pai, Rish [6 ]
Reinisch, Walter [7 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Hosp Sao Joao, Porto, Portugal
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Robarts Clin Trials Inc, London, ON, Canada
[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[6] Mayo Clin, Scottsdale, AZ USA
[7] Med Univ Vienna, Vienna, Austria
来源：
GUT | 2022年 / 71卷
关键词：
D O I：
10.1136/gutjnl-2022-BSG.74
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P12
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [1] Association of histologic measurement with endoscopic outcomes after one year of treatment with mirikizumab in patients with moderate to severe Crohn's Disease
    Magro, F.
    De Hertogh, G.
    Protic, M.
    Chan, L. S.
    Pollack, P.
    Feagan, B. G.
    Harpaz, N.
    Pai, R.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I129 - I130
  • [2] ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE BY BASELINE DISEASE SEVERITY
    Siegmund, Britta
    Patel, Kamal V.
    Torres, Esther A.
    Lakatos, Peter L.
    Seidelin, Jakob B.
    Fleisher, Mark
    Ford, Sharanya
    Remple, Valencia
    Lacerda, Ana P.
    Anyanwu, Samuel
    Garrison, Andrew
    Panes, Julian
    GASTROENTEROLOGY, 2023, 164 (06) : S1103 - S1103
  • [3] Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease Patients
    Di Fonzo, David M. P.
    Alabdulkarim, Balqis
    Yanofsky, Russell
    Abduallah, Yaqeen
    Golovics, Petra
    Lakatos, Peter L.
    Bitton, Alain
    Wild, Gary
    Afif, Waqqas
    Bessissow, Talat
    CROHNS & COLITIS 360, 2024, 6 (04)
  • [4] Histologic disease activity correlates with endoscopic severity in patients with moderate to severe Crohn's Disease
    Reinisch, W.
    De Hertogh, G.
    Protic, M.
    Chan, L. S.
    Magro, F.
    Pollack, P.
    Feagan, B. G.
    Harpaz, N.
    Pai, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I103 - I105
  • [5] EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
    Sands, Bruce E.
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Higgins, Peter D.
    Hirai, Fumihito
    Jairath, Vipul
    D'Haens, Geert
    Abreu, Maria T.
    Belin, Ruth
    Valderas, Elisa Gomez
    Miller, Debra
    Naegeli, April N.
    Arora, Vipin
    Pollack, Paul
    Tuttle, Jay
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2021, 160 (06) : S37 - S37
  • [6] Use of antidepressants in patients with moderate-to-severe Crohn's disease
    Lichtenstein, GR
    Colombel, JF
    Yan, S
    Bala, M
    Olson, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S250 - S251
  • [7] Impact of mirikizumab on histologic measures of intestinal inflammation in a phase 2 study of patients with moderate-severe crohn's disease
    Pai, Rish
    De Hertogh, Gert
    Reinisch, Walter
    Harpaz, Noam
    Feagan, Brian
    Agada, Noah
    Pollack, Paul
    Chan, Lai Shan
    Protic, Marijana
    Magro, Fernando
    Dhesi, Endip
    GUT, 2023, 72 (SUPPL_2) : A210 - A210
  • [8] Upadacitinib for the treatment of moderate-to-severe Crohn's disease
    Hanzel, Jurij
    Ma, Christopher
    Jairath, Vipul
    IMMUNOTHERAPY, 2024, 16 (06) : 345 - 357
  • [9] A new treatment for moderate-to-severe Crohn's disease
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2008, 108 (05) : 65 - 65
  • [10] Endoscopic and clinical outcomes of upadacitinib in patients with moderate to severe Crohn's disease by baseline disease severity
    Siegmund, B.
    Patel, K.
    Torres, E. A.
    Lakatos, P. L.
    Seidelin, J.
    Fleisher, M.
    Ford, S.
    Remple, V.
    Lacerda, A. P.
    Anyanwu, S.
    Garrison, A.
    Panes, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 636 - 637
12345